FluoroPharma to Present Phase I Study Results of Novel Positron Emission Tomography (PET) Myocardial Perfusion Imaging (MPI) Tracer
BOSTON, June 15 /PRNewswire/ -- FluoroPharma Inc., a company developing breakthrough PET molecular imaging agents, announced that it will present Phase I data relating to the safety, dosimetry, and pharmacokinetics in human subjects of BFPET, its novel 18-F labeled PET tracer for myocardial
Fatigue common after myocardial infarction
Half of all patients who undergo myocardial
infarction are experiencing onerous fatigue four months after the infarction. The patients who are most fatigued are those who perceive the infarction as a sign of chronic illness, those who experience the illness as difficult to control, and those who b...
For ST-Elevation Myocardial Infarction (STEMI), Interviewed Experts Indicate That The Medicines Company's Angiomax/Angiox Has Efficacy Advantages Over Sales-Leading ReoPro
Angiomax/Angiox Will Retain Decision Resources' Gold-Standard Status in 2017 for the Treatment of STEMI with Percutaneous Coronary Intervention, According to a New Report from Decision Resources
WALTHAM, Mass., April 23 /PRNewswire/ -- Decision Resources, one of the world's leading research a...
An ESC statement on gender differences in medical care and survival after myocardial infarction
A paper published online by the journal Circulation on 8 December 2008 concluded that, while men and women have a similar in-hospital death rate following acute myocardial
infarction, women with STEMI had an adjusted mortality rate almost twice as high as men (10.2% versus 5.5%). These differenc...
New System Devised To Guide Doctors Treating Patients With Symptomatic Myocardial Bridging
Symptoms, non-invasive tests, and heart flow tests combine to reduce subjective decision-making
Los Angeles (PRWEB) July 1, 2008 -- What type of intervention, if any, should cardiologists offer their patients who have a heart abnormality called myocardial
bridging and s...
New system devised to guide doctors treating patients with symptomatic myocardial bridging
LOS ANGELES (June 25, 2008) What type of intervention, if any, should cardiologists offer their patients who have a heart abnormality called myocardial
bridging and symptoms of heart problems?
A research team at Cedars-Sinai Medical Center, the University of Texas Medical Branch and RWTH Aache...
Myocardial in Medical Technology
FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
BOSTON, July 23 /PRNewswire/ -- FluoroPharma Inc., a company developing
breakthrough molecular imaging agents for the Positron Emission Tomography
(PET) market, announced positive Phase I results for BFPET, its novel
Fluorine-18 labeled tracer for myocardial
perfusion imaging. BFPET is
FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
BOSTON, March 19 /PRNewswire/ -- FluoroPharma Inc., a company
developing breakthrough cardiovascular molecular imaging agents for the
Positron Emission Tomography (PET) market, announced commencement of Phase
I clinical trials for BFPET, following institutional review board (IRB)
approval of t...
Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
ORLANDO, Fla., Nov. 7 /PRNewswire-FirstCall/ -- A retrospective
analysis of healthcare claims in more than 20,000 patients with type 2
diabetes from an integrated U.S. national managed care database found that
the initiation of insulin therapy with insulin glargine was associated with
a lower ...
Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI)
PALO ALTO, Calif., Aug. 15 /PRNewswire-FirstCall/ -- CV Therapeutics,
Inc. (Nasdaq: CVTX ) announced today that new guidelines, developed jointly
by the American College of Cardiology Foundation and the American Heart
Association and published in this week's issue of Circulation, state that,
VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE
...tes to monocyte deployment from the spleen to inflammatory sites, including myocardial
infarction. The findings are expected to open up new areas of research and...ance therapeutic approaches to key disease areas including inflammation and myocardial
In the SCIENCE report, entitled " Identification of Spleni...
Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome
...Increases in HDL, the "good" cholesterol and increased insulin sensitivity have also been documented along with a robust improvement in thrombosis and myocardial
The Cardax drug reduces systemic inflammation and oxidative stress while localizing in the liver and the vasculature. Cellular studi...
Myocardial in Medical Products
Myocardial in Medical Definition
...ce January 2007 .
Arteries stiffen as a consequence of age and atherosclerosis . The two leading causes of death in the developed world, myocardial
infarction and stroke , are both a direct consequence of atherosclerosis and increased arterial stiffness is associated with an increased risk of ca...
...e nephropathy - Secondary hypertension - Renovascular hypertension
Ischaemic heart disease
Angina pectoris - Prinzmetal's angina - myocardial
infarction - Dressler's syndrome
Pulmonary embolism - Cor pulmonale
Pericarditis - Car...
Myocardial in Medical Dictionary
...blood flow to the heart ... Your doctor will probably diagnose unstable angina if you are having chest pain ... Unstable angina and myocardial
infarction are considered acute coronary ... Unstable angina occurs in approximately 6 out of every 10,000 people. ... Angina literally ...
...tis are a heart ... Pericarditis - its causes, diagnosis, and treatment ... Pericarditis occurs in up to 15% of patients who have acute myocardial
... Pericarditis information including symptoms, diagnosis, misdiagnosis, treatment, causes, patient stories, videos, forums, prevention, and pr...
... the term refers to a functional effect of... myocardial
contusion is a "bruise" of the heart muscle. ...Basic safety precautions are keys to preventing myocardial
contusion . ... myocardial
contusion is a ... ...
infarction , commonly known as a heart attack, o... occlusion (blockage) of a coronary artery... myocardial
infarction n An occlusion or blockage of arteri... (myocardium), usually the result of a focal ... myocardial
ischemia or infarction ... Insufficient ...
..... A patient information handout on Kawasaki disease , written by an AAFP staff ... The principal cause of death from Kawasaki disease is myocardial
infarction. ... Patient information: A handout on Kawasaki disease , written by the authors of ... Kawasaki disease is an acute vasculit...
...re recovered in virus, ... A number of intracellular signaling chemicals are fixed to subcellular ... Protective Role of Intracellular Zinc in myocardial
Ischemia/Reperfusion Is ... Information about intracellular in the free online ... Intracellular Adhesion Molecules. Intracellular bacterici...
Myocardial in Biological News
Periodontitis and myocardial infarction: A shared genetic predisposition
This release is available in German .
A mutual epidemiological relationship between aggressive periodontitis and myocardial
infarction has already been shown in the past. Scientists at the universities of Kiel, Dresden, Amsterdam and Bonn have now presented the first evidence of a shared g...
Geron Demonstrates hESC-derived cardiomyocytes improve heart function after myocardial infarction
MENLO PARK, Calif., Aug. 27, 2007 Geron Corporation (Nasdaq: GERN) today reported its scientists and collaborators have demonstrated that human embryonic stem cell (hESC)-derived cardiomyocytes improve heart function when transplanted after myocardial
Published online Aug. 26 in N...
Adult bone marrow stem cells injected into skeletal muscle can repair heart tissue
...ed by MSCs improved ventricular function, promoted myocardial
regeneration, lessened apoptosis (cell death) and ...recruited bone marrow progenitor cells and induced myocardial
expression of multiple growth factor genes," Lee s...donor hearts are very scarce.
Clinical trials of myocardial
stem cell therapy traditionally have relied on sur...
MDC researchers prevent virus induced myocarditis
The receptor used by the Coxsackievirus to infect the heart is the Coxsackie-adenovirus-receptor (CAR). It can be found in the cell membrane of myocardial
fibers. Ulrike Lisewski, Dr. Shi, Michael Radke, and Prof. Gotthardt discovered only recently that CAR is necessary for a regular heart beat.
SNM Symposium on Multimodality Cardiovascular Molecular Imaging
...ar system, including imaging of cardiovascular receptors, vascular biology, myocardial
metabolism and myocardial
SNM and the International Partnership for Critical Markers of D...
Plasminogen activator inhibitor type-1 -- a potential link between heart failure and diabetes
...uting to the high incidence of heart failure after myocardial
infarction in people with diabetes. The research ...eart altered the response of the left ventricle to myocardial
infarction. It led to increased expression of PAI... incidence and severity of heart failure following myocardial
infarction in patients with insulin resistance and...
Myocardial in Biological Technology
InspireMD Announce the Completion of Enrollment for the MAGICAL Trial (MGuard(TM) in Acute Myocardial Infarction) at EuroPCR '09. Results Will be Presented May 21st by Dr. Dariusz Dudek at the InspireMD Cocktail Reception Debate Chaired by Prof. Martin Le
BARCELONA, Spain, May 20 /PRNewswire/ -- InspireMD, Ltd. announced today
the completion of enrolment for the MAGICAL trial (MGuard(TM) in Acute
Myocardial). The trial was designed to confirm the clinical feasibility,
safety and performance of MGuard when used during Primary PCI in STEMI
InspireMD Announces Enrollment of First Patients in the MGuard(TM) Acute Myocardial Infarction Clinical Trial Data Will be Used to Confirm Initial Positive Results
TEL AVIV, Israel, September 23 /PRNewswire/ -- InspireMD, Ltd.
announced today the enrollment of the first 3 patients in its study of
MGuard(TM) coronary stent in acute myocardial
infarction. The GUARD Study
(MGuard(TM) in Acute Myocardial
Infarction Study) is designed to evaluate
the safety a...
With the BEAUTIFUL Results, Procoralan* (ivabradine) is the First Antianginal Treatment Shown to Reduce Myocardial Infarction (Heart Attack) and Revascularisation in Stable Coronary Patients
MUNICH, Germany, August 31 /PRNewswire/ --
Press conference The BEAUTIFUL study: a step further in title Coronary Artery Disease
ESC Hotline Title: The BEAUTIFUL study: efficacy of session title ivabradine in reduction of cardiovascular ...
Astellas Launches Lexiscan(TM) (Regadenoson) Injection for Use as a Pharmacologic Stress Agent in Radionuclide Myocardial Perfusion Imaging (MPI)
-First A2A Adenosine Receptor Agonist Approved for Use in Identifying Coronary Artery Disease-
DEERFIELD, Ill., June 24 /PRNewswire/ -- Astellas Pharma US, Inc. today
announced the commercial availability of Lexiscan(TM) (regadenoson)
injection, an A2A adenosine recepto...
OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Feasible in Acute Myocardial Infarction Patients, American Heart Journal Paper Reports
HONG KONG, Feb. 15 /PRNewswire/ -- OrbusNeich's Genous(TM)
Bio-engineered R stent(TM) is feasible and safe for use in acute myocardial
infarction (AMI) patients, according to a paper published in the American
Heart Journal (2008; Vol. 155, Issue 1: 128-132).
The paper, based on a study of 12...
Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
CLEVELAND, OH and VANCOUVER, Dec. 20 /PRNewswire-FirstCall/ - Athersys,
Inc. (Nasdaq: ATHX ) and Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX:
ANP), announced today that Athersys has received authorization from the
U.S. Food and Drug Administration (FDA) to begin a Phase I clinical tria...
Myocardial in Biological Definition
...s from omission of insulin, mismanagement of acute gastroenteritis (the "flu"), or an overwhelming new health problem (e.g., bacterial infection , myocardial
Insulin deficiency switches many aspects of metabolic balance in a catabolic direction. The liver becomes a net producer of gluco...
Myocardial in Biological Dictionary
...directed gene modification ... To monitor endogenous gene modification by TFOs in a yeast model, we inactivated ... DELIVERY STRATEGIES FOR myocardial
GENE TRANSFER IN PRECLINICAL STUDIES ... with the differentiation potential of the cells after gene modification . ... · Somatic cell g...
...ng Goods, Toys, Collectibles, Car Parts, Food, and the Good Things in Life. Addition of adenosine to cardioplegic fluid has been shown to improve myocardial
... Adenosine treatment did not modify the late hepatotoxic effect of the carbon ... Adenosine slows those tachycardias associated with the AV ...